| Literature DB >> 19031944 |
Guido Poggi1, Pietro Quaretti, Claudio Minoia, Ilaria Palumbo, Laura Villani, Alessio Amatu, Cristina Teragni, Mario Scelsi, Federico Zappoli, Giovanni Bernardo.
Abstract
Intrahepatic cholangiocarcinoma account for 13% of annual cancer-related deaths worldwide and for 3% in the USA. Patient with unresectable disease can benefit from palliative therapies such as systemic chemotherapy. However, the only curative treatment for intrahepatic cholangiocarcinoma is complete surgical resection with histologically negative resection margins.Entities:
Mesh：
Substances：
Year: 2008 PMID： 19031944
Source DB: PubMed Journal: Anticancer Res ISSN： 0250-7005 Impact factor: 2.480